Hainan Shuangcheng Pharmaceut (002693) - Total Liabilities
Based on the latest financial reports, Hainan Shuangcheng Pharmaceut (002693) has total liabilities worth CN¥381.09 Million CNY (≈ $55.77 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Hainan Shuangcheng Pharmaceut (002693) long-term investment share to see how much of total assets are deployed in long-term investments.
Hainan Shuangcheng Pharmaceut - Total Liabilities Trend (2009–2025)
This chart illustrates how Hainan Shuangcheng Pharmaceut's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Hainan Shuangcheng Pharmaceut (002693) total assets.
Hainan Shuangcheng Pharmaceut Competitors by Total Liabilities
The table below lists competitors of Hainan Shuangcheng Pharmaceut ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Anhui Huaertai Chemical Co Ltd
SHE:001217
|
China | CN¥1.22 Billion |
|
Zhejiang Sf Oilless Bearing Co Ltd
SHE:300817
|
China | CN¥259.79 Million |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥1.87 Billion |
|
SAPPI LTD ADR/1 RC 1
F:SPIA
|
Germany | €3.65 Billion |
|
Kunming Yunnei Power Co Ltd
SHE:000903
|
China | CN¥9.00 Billion |
|
Tilray Inc
NASDAQ:TLRY
|
USA | $733.14 Million |
|
Shanghai Kinlita Chemical Co
SHE:300225
|
China | CN¥506.06 Million |
|
Peet Ltd
AU:PPC
|
Australia | AU$403.77 Million |
Liability Composition Analysis (2009–2025)
This chart breaks down Hainan Shuangcheng Pharmaceut's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Hainan Shuangcheng Pharmaceut to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.62 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.89 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hainan Shuangcheng Pharmaceut's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hainan Shuangcheng Pharmaceut (2009–2025)
The table below shows the annual total liabilities of Hainan Shuangcheng Pharmaceut from 2009 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥405.25 Million ≈ $59.30 Million |
+8.86% |
| 2024-12-31 | CN¥372.26 Million ≈ $54.47 Million |
+30.34% |
| 2023-12-31 | CN¥285.60 Million ≈ $41.79 Million |
-13.47% |
| 2022-12-31 | CN¥330.08 Million ≈ $48.30 Million |
+14.69% |
| 2021-12-31 | CN¥287.80 Million ≈ $42.11 Million |
-6.97% |
| 2020-12-31 | CN¥309.37 Million ≈ $45.27 Million |
+13.44% |
| 2019-12-31 | CN¥272.72 Million ≈ $39.91 Million |
-39.47% |
| 2018-12-31 | CN¥450.56 Million ≈ $65.93 Million |
-26.79% |
| 2017-12-31 | CN¥615.41 Million ≈ $90.05 Million |
+0.49% |
| 2016-12-31 | CN¥612.40 Million ≈ $89.61 Million |
-1.63% |
| 2015-12-31 | CN¥622.56 Million ≈ $91.10 Million |
+1145.41% |
| 2014-12-31 | CN¥49.99 Million ≈ $7.31 Million |
+7.68% |
| 2013-12-31 | CN¥46.42 Million ≈ $6.79 Million |
+13.78% |
| 2012-12-31 | CN¥40.80 Million ≈ $5.97 Million |
+105.79% |
| 2011-12-31 | CN¥19.83 Million ≈ $2.90 Million |
-79.11% |
| 2010-12-31 | CN¥94.92 Million ≈ $13.89 Million |
+376.80% |
| 2009-12-31 | CN¥19.91 Million ≈ $2.91 Million |
-- |
About Hainan Shuangcheng Pharmaceut
Hainan Shuangcheng Pharmaceuticals Co., Ltd. engages in research and development, production, and sale of pharmaceutical injections, solid preparations, and raw materials in China and internationally. The company offers products for oncology and immune, alimentary canal, heart and cerebral, and vessels and metabolism. It also provides Bivalirudin, Epitifibatide, and Thymalfaxin for injection; Pre… Read more